Search

Search Constraints

You searched for: Author/Creator Buonfiglioli, F.

Search Results

1. Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice. (10th February 2016)

2. Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Issue 1 (February 2018)

3. Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients. Issue 1 (16th February 2017)

5. OC.16.6 A MODEL OF RELOCATION OF GASTROENTEROLOGICAL PROCEDURES SUSPENDED DURING FIRST COVID 19 LOCKDOWN: THE EXPERIENCE OF BOLOGNA EMERGENCY GASTROPACK PROJECT. (May 2022)

6. P.01.4 THE GASTROPACK SYSTEM, A NOVEL METHOD TO ACCESS TO GASTROENTEROLOGICAL CARE: RESULTS OF THE UPPER GASTROINTESTINAL SYMPTOM POPULATION. (25th March 2019)

7. Safety and efficacy of direct‐acting antivirals for the treatment of chronic hepatitis C in a real‐world population aged 65 years and older. Issue 6 (2nd February 2017)

9. T01.01.5 THE GASTROPACK SYSTEM AS A MODEL FOR EGD APPROPRIATENESS IN PATIENTS WITH UPPER GASTROINTESTINAL SYMPTOMS: A COMPARISON WITH THE OPEN ACCESS SYSTEM. (1st October 2020)

10. Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study. (10th February 2016)